Maureen Bolon is an Infectious Disease physician affiliated with Northwestern University. OpenAlex indexes 84 publications with 6,431 citations (h-index 26); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
676 N Saint Clair St Ste 940
Chicago, IL 606112945
Telephone
312-926-8358Provider last certified this registry record 10 Jan 2020.
Clinical trials
- Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
91%Glycopeptide Antibacterial12.8%Vancomycin Hcl100%Part D<11 patientsCephalosporin Antibacterial10.9%Ceftriaxone55%Cefoxitin45%Part D<11 patients+ 10 more classes in this area
Respiratory
9%Opioid Agonist9%Hydrocodone-Acetaminophen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- <i>Candida auris</i> outbreak in a cardiothoracic transplant intensive care unit: implications for infection prevention practices and keeping pace with an evolving landscape
Infection Control and Hospital Epidemiology
2025 - Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity
Clinical Pharmacology & Therapeutics
2025 - Identifying <i>Candida auris</i> transmission in a hospital outbreak investigation using whole-genome sequencing and SNP phylogenetic analysis
Journal of Clinical Microbiology
2024 - Mycobacteroides abscessus outbreak and mitigation in a cardiothoracic transplant population: the problem with tap water
Journal of Hospital Infection
2024 - A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients
Clinical Microbiology and Infection
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University
Philip Greenland, MD
Northwestern University
Peter Kahrilas, MD
Northwestern University
Philip Gorelick, MD
Northwestern University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”